JPM
JPMorgan Chase & Co.
JPM has the edge over RNR overall, supported by stronger modeled upside and lower modeled downside.
RNR
RenaissanceRe Holdings Ltd.
RNR trails on the overall score without a compensating advantage in the available component scores.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
RNR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Strong | |
| N/A | |
| N/A |
RNR's profitability is currently strong, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like RNR.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over RNR in the historical PE scenario, which offers more potential upside but is not a forecast.
RNR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5x | $171 | -52% |
| Fair | 7.4x | $256 | -28% |
| Forward | 8.4x | $355 | — |
| Current | 10x | $355 | — |
| Expensive | 15x | $500 | +41% |
Historical ranges are pointers, not guarantees.
RNR's PE is in its fair range at 10x. On analysts' estimates for next year's earnings, today's price would be 8.4x.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
RNR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Decline | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RNR's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over RNR on earnings, with more consistent year-over-year improvement.
RNR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $42.22 | +22% |
| Q3 2026 | $34.47 | -4.5% |
| Q2 2026 | $57.88 | +47% |
| Q1 2026 | $59.33 | +88% |
| Q4 2025 | $56.03 | +59% |
| Q3 2025 | $36.11 | -49% |
| Q2 2025 | $39.33 | -24% |
| Q1 2025 | $31.54 | -32% |
| Q4 2024 | $35.21 | -33% |
RNR's earnings per share have fallen from their peak: $34.47 over the past year, against $70.44 in late 2024.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over RNR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over RNR on profitability, with a higher operating margin.
RNR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | -47% |
| Q2 2026 | $2.8B | -14% |
| Q1 2026 | $2.2B | -37% |
| Q4 2025 | $3B | +30% |
| Q3 2025 | $3.2B | -20% |
| Q2 2025 | $3.2B | +13% |
| Q1 2025 | $3.5B | +34% |
| Q4 2024 | $2.3B | -29% |
RNR's revenue has slid since its 2024 peak: $1.7B last quarter, down 47% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.9% | -48 points |
| Q2 2026 | 40% | -1.4 points |
| Q1 2026 | 25% | +27 points |
| Q4 2025 | 43% | +46 points |
| Q3 2025 | 46% | +2.6 points |
| Q2 2025 | 42% | +17 points |
| Q1 2025 | -2% | -26 points |
| Q4 2024 | -3.6% | -48 points |
RNR's operating margin was −1.9% last quarter, down 48 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
RNR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $794.5M | -50% |
| Q2 2026 | $852.4M | -42% |
| Q1 2026 | $687.6M | +336% |
| Q4 2025 | $483M | -38% |
| Q3 2025 | $1.6B | +6.2% |
| Q2 2025 | $1.5B | +21% |
| Q1 2025 | $157.8M | -77% |
| Q4 2024 | $778.9M | +52% |
RNR has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
RNR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3% | -1.3M shares |
| 1 year | -12% | -5.7M shares |
| 3 years | -20% | -10.1M shares |
| 5 years | -13% | -5.9M shares |
| Available history | -7.5% | -3.3M shares |
RNR has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $310.1M |
| Q2 2026 | $350.5M |
| Q1 2026 | $352M |
| Q4 2025 | $660M |
| Q3 2025 | $208.3M |
| Q2 2025 | $373.6M |
| Q1 2025 | $357.7M |
| Q4 2024 | $451.6M |
RNR spent $1.7B buying back its own shares over the past year, up 20% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
RNR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | 0.1x | Very low |
RNR has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
RNR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.5 | Neutral |
| Stochastic | 66.9 | Neutral |
RNR's weekly RSI is 67 (neutral) and its Stochastic is 67 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
RNR PE vs Financial Services Sector
| Metric | RNR | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 21% below |
| PE % | 62 | 63 | 1 pt below |
RNR has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
RNR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $340.9 | 4% above |
| 20 week MA | $331.1 | 7.1% above |
| 50 week MA | $307.5 | 15% above |
| 100 week MA | $276.5 | 28% above |
| 200 week MA | $248.0 | 43% above |
RNR has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
RNR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $195.7 | $161.4 | -18% |
| 2021 | $161.4 | $167.7 | +3.9% |
| 2022 | $167.7 | $186.9 | +11% |
| 2023 | $186.9 | $196.0 | +4.9% |
| 2024 | $196.0 | $250.6 | +28% |
| 2025 | $250.6 | $281.4 | +12% |
| 2026 YTD | $281.4 | $354.7 | +26% |
RNR has the edge over JPM on returns for 2026, with the stronger performance.